Edition:
United Kingdom

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.66USD
20 Nov 2018
Change (% chg)

$-0.01 (-1.93%)
Prev Close
$0.67
Open
$0.70
Day's High
$0.70
Day's Low
$0.63
Volume
101,260
Avg. Vol
210,244
52-wk High
$3.34
52-wk Low
$0.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Feb-18 2 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.10 0.10 0.10 --
Year Ending Feb-18 2 0.00 0.00 0.00 --
Year Ending Mar-19 3 2.26 6.49 0.00 --
Year Ending Mar-20 2 0.64 1.28 0.00 --
Earnings (per share)
Quarter Ending Feb-18 1 -0.20 -0.20 -0.20 --
Quarter Ending Mar-19 1 -0.17 -0.17 -0.17 --
Year Ending Feb-18 2 -0.64 -0.29 -0.98 --
Year Ending Mar-19 3 -0.51 -0.34 -0.73 --
Year Ending Mar-20 2 -0.27 -0.14 -0.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.23 33.59
P/E High - Last 5 Yrs. -- 40.67 45.05
P/E Low - Last 5 Yrs. -- 24.06 24.37
Beta -- 0.92 0.91
Price to Sales (TTM) -- 4.01 5.69
Price to Book (MRQ) -- 5.04 5.11
Price to Tangible Book (MRQ) -- 5.77 6.54
Price to Cash Flow (TTM) -- 23.28 23.52
% Owned Institutions -- 0.96 1.86

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.48
Dividend Yield - 5 Year Avg -- 1.55 1.50
Dividend 5 Year Growth Rate -- 4.20 5.09
Payout Ratio(TTM) -- 45.75 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.38 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 4.87 5.86
Sales - 5 Yr. Growth Rate -- 10.03 10.16
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 17.59 21.17
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.81 10.63
Capital Spending - 5 Yr. Growth Rate -- 15.39 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.26
Current Ratio (MRQ) -- 3.02 3.09
LT Debt to Equity (MRQ) -- 8.92 11.53
Total Debt to Equity (MRQ) -- 12.75 15.71
Interest Coverage (TTM) -- 35.11 32.22

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.28 54.07
Gross Margin - 5 Yr. Avg. -- 51.72 51.83
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.38 11.80
Operating Margin (TTM) -- 14.42 4.85
Operating Margin - 5 Yr. Avg. -- 14.54 7.45
Pre-Tax Margin (TTM) -- 14.94 5.82
Pre-Tax Margin - 5 Yr. Avg. -- 14.96 7.86
Net Profit Margin (TTM) -- 11.15 2.08
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.10
Effective Tax Rate (TTM) -- 23.47 23.39
Effective Tax Rate - 5 Yr. Avg. -- 23.63 24.13

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 1,003,835,119 905,637,302
Net Income/Employee (TTM) -- 119,027,128 107,327,405
Receivable Turnover (TTM) -- 5.83 5.95
Inventory Turnover (TTM) -- 2.68 3.63
Asset Turnover (TTM) -- 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 12.00 11.52
Return on Assets - 5 Yr. Avg. -- 13.31 12.71
Return on Investment (TTM) -- 15.57 15.05
Return on Investment - 5 Yr. Avg. -- 17.33 16.50
Return on Equity (TTM) -- 16.94 16.62
Return on Equity - 5 Yr. Avg. -- 18.26 17.61
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.